NYSE:EW

Edwards Lifesciences Stock Insider Trading

Healthcare > Medical - Devices

Buy EW

*Your capital is at risk

$91.79

-0.420 (-0.455%)

At Close: Jul 13, 2026

Edwards Lifesciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 9.92. In total, the insiders bought 1.08M and sold 2.03B EW shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	9.92
● Buy	1.08M shares
● Sell	2.03B shares
58% Buy Activity Moderate Positive Correlation
Sell Signal Low Confidence May 12, 2026 Analysis Breakdown: Weakened by a contradictory positive Insider Power Score. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jul 11, 2026 Sell	Common Stock F-InKind	Bruls Annette Cvp, Emeacla	Officer	109 Value: $10.1K
Jul 10, 2026 Buy	Employee Stock Option (Right to Acquire) M-Exempt	Lippis Daniel J. Cvp, Tavr	Officer	619 Value: $45.0K
Jul 10, 2026 Sell	Common Stock S-Sale	Lippis Daniel J. Cvp, Tavr	Officer	619 Value: $56.8K
Jul 10, 2026 Buy	Common Stock M-Exempt	Lippis Daniel J. Cvp, Tavr	Officer	619 Value: $45.0K
Jul 09, 2026 Buy	Common Stock A-Award	Mistras Theodora Cvp, Chief Financial Officer	C-Suite Officer	12 325 Value: $1.13M
Jul 09, 2026 Buy	Employee Stock Option (Right to Acquire) A-Award	Mistras Theodora Cvp, Chief Financial Officer	C-Suite Officer	61 800 Value: $5.64M
Jul 09, 2026 Buy	Common Stock A-Award	Mistras Theodora Cvp, Chief Financial Officer	C-Suite Officer	87 595 Value: $8.00M
Jul 09, 2026 Buy	Performance Rights A-Award	Mistras Theodora Cvp, Chief Financial Officer	C-Suite Officer	12 325 Value: $1.13M
Jul 07, 2026 Sell	Common Stock F-InKind	Lippis Daniel J. Cvp, Tavr	Officer	377 Value: $35.9K
Jun 30, 2026 Sell	Common Stock S-Sale	Lippis Daniel J. Cvp, Tavr	Officer	619 Value: $56.6K
Jun 30, 2026 Buy	Employee Stock Option (Right to Acquire) M-Exempt	Lippis Daniel J. Cvp, Tavr	Officer	619 Value: $45.0K
Jun 30, 2026 Buy	Common Stock M-Exempt	Lippis Daniel J. Cvp, Tavr	Officer	619 Value: $45.0K
Jun 17, 2026 Sell	Common Stock S-Sale	Zovighian Bernard J CEO	CEO / President	523 Value: $46.0K
May 29, 2026 Buy	Common Stock J-Other	Mistras Theodora Officer	Officer	0 Value: $0
May 29, 2026 Sell	Common Stock S-Sale	Dahl Andrew M. SVP, Corporate Controller	Officer	568 Value: $48.9K
May 27, 2026 Sell	Common Stock S-Sale	Bobo Donald E Jr Cvp,strategy/corp Development	Officer	23 145 Value: $2.00M
May 22, 2026 Sell	Common Stock S-Sale	Chopra Daveen Cvp, Tmtt & Surgical	Officer	1 500 Value: $126.9K
May 18, 2026 Buy	Employee Stock Option (Right to Acquire) M-Exempt	Lippis Daniel J. Cvp, Tavr	Officer	620 Value: $45.1K
May 18, 2026 Sell	Common Stock S-Sale	Lippis Daniel J. Cvp, Tavr	Officer	620 Value: $50.3K
May 18, 2026 Buy	Common Stock M-Exempt	Lippis Daniel J. Cvp, Tavr	Officer	620 Value: $45.1K
May 15, 2026 Sell	Common Stock S-Sale	Bobo Donald E Jr Cvp,strategy/corp Development	Officer	8 000 Value: $654.6K
May 15, 2026 Sell	Common Stock S-Sale	Bobo Donald E Jr Cvp,strategy/corp Development	Officer	9 968 Value: $818.1K
May 12, 2026 Buy	Common Stock G-Gift	Zovighian Bernard J CEO	CEO / President	26 640 Value: $2.12M
May 12, 2026 Sell	Common Stock S-Sale	Zovighian Bernard J CEO	CEO / President	845 Value: $66.3K
May 12, 2026 Sell	Common Stock S-Sale	Zovighian Bernard J CEO	CEO / President	35 506 Value: $2.77M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT EDWARDS LIFESCIENCES CORPORATION

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the P...

Read Full Profile Here